Experiences of key populations in multidrug-resistant TB and HIV.
H Nyilana, K Reis, B Seepamore, R Perumal, A Wolf, K Guzman, K R Amico, M Zulu, et al. (19 authors)
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2025-06
Abstract
Key populations for multidrug-resistant TB (MDR-TB) face heightened vulnerability due to social, behavioral, and structural barriers, such as poverty, substance use and stigma. Here we illustrate the difficulties faced with a composite personal narrative based on the experiences of two participants in a clinical trial of adherence support interventions for people with MDR-TB and HIV. Addressing these factors through tailored interventions is crucial to improving care engagement and challenging one-size-fits-all approaches to TB prevention.
MeSH terms
- Humans
- Tuberculosis, Multidrug-Resistant
- HIV Infections
- Medication Adherence
- Male
- Antitubercular Agents
- Social Stigma
- Female
- Adult
- Poverty